Gemini Israel IV Limited Partnership - Former 10% Owner at Teads Holding Co.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Gemini Israel IV Limited Partnership since 19 Aug 2025

Reported holdings for Gemini Israel IV Limited Partnership in Teads Holding Co.

Form 4 holding Former 10% Owner

Outbrain Inc.

Security class
Common Stock
Shares / value
4,921,763
Estimated value
$20,917,493
Report date
27 Jul 2021
Price
$4.25
Ownership
Direct
Form 4 holding Former 10% Owner

Outbrain Inc.

Security class
Series A Preferred Stock
Shares / value
0
Estimated value
Report date
27 Jul 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Former 10% Owner

Outbrain Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
27 Jul 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Former 10% Owner

Outbrain Inc.

Security class
Series C Preferred Stock
Shares / value
0
Estimated value
Report date
27 Jul 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Former 10% Owner

Outbrain Inc.

Security class
Series F Preferred Stock
Shares / value
0
Estimated value
Report date
27 Jul 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Gemini Israel IV Limited Partnership in Teads Holding Co.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .